Fortis files suit to recover Rs 520 crore from Malvinder, Shivinder Singh

In October, the Sebi had directed Fortis to take necessary action to recover Rs 403 cr from Singh brothers

Fortis files suit to recover Rs 520 crore from Malvinder, Shivinder Singh
Sohini Das Mumbai
2 min read Last Updated : Aug 15 2019 | 12:16 AM IST
Hospital major Fortis Healthcare has filed a civil suit against its former promoters — brothers Malvinder Singh and Shivinder Singh — and other entities to recover Rs 520 crore from them. The lawsuit was filed in the Delhi High Court on Tuesday.

The Gurugram-headquartered firm confirmed the development. “Fortis Hospitals has filed a suit against Best Healthcare, Fern Healthcare, Modland Wears, Malvinder Mohan Singh, Shivinder Mohan Singh and certain other entities... The suit is sub-judice. At present, we have no further comments,” the company said. 


Malvinder and Shivinder Singh could not be reached for comment. 

In October, the Securities and Exchange Board of India (Sebi) had directed Fortis to take necessary action to recover Rs 403 crore from Singh brothers along with due interest within 90 days. They had allegedly siphoned off the amount from the company.

The Sebi order had also named other entities including RHC Holding, Shivi Holdings, Malav Holdings, Religare Finvest, Best Healthcare, Fern Healthcare and Modland Wears.

The order came after an investigation by the market regulator found that funds were being diverted to entities related to the former promoters. 


Japanese drugmaker Daiichi Sankyo had moved the Delhi High Court seeking Rs 3,500 crore from the brothers and asked the court for direction in the matter. Daiichi had won an arbitration award in a Singapore tribunal which asked the brothers to pay Rs 3,500 crore to the drugmaker. 

In the first week of August, the Enforcement Directorate had searched the residences of former promoters in New Delhi in connection with a money laundering case.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Ranbaxy Laboratories Malvinder Singh Shivinder Mohan SinghMalvinder Singh and Shivinder SinghFortis HealthcareMalvinder and Shivinder SinghSingh brothersFortis probeShivinder-Malvinder spatFortis Healthcare caseFortis Healhcare

Next Story